by Damon Race | Nov 30, 2020 | In the News
Latest spinoff from UNC’s Gene Therapy Center wants to find a cure for hemophilia Read more here: https://www.newsobserver.com/news/business/article247379109.html#storylink=cpy RALEIGH UNC-Chapel Hill’s gene therapy center has birthed yet another startup in the...
by Damon Race | Nov 6, 2020 | In the News
By Seth Thomas Gulledge – Staff Writer, Triangle Business Journal – November 4, 2020 Companies in this article: University of North Carolina at Chapel Hill https://www.unc.edu/, GeneVentiv Therapeutics https:/www.geneventiv.com A new company launching around...
by Damon Race | Nov 6, 2020 | In the News
by Meredith Dockery, North Carolina Business News Wire — November 4, 2020 . RALEIGH — GeneVentiv Therapeutics, Inc., a gene therapy developer, announced a license agreement with the University of North Carolina at Chapel Hill for a patent-pending, gene therapy for...
by daniel | Oct 30, 2020 | In the News
November 2, 2020 RALEIGH, NC – GeneVentiv Therapeutics has entered a license agreement with University of North Carolina Chapel Hill for a gene therapy that is a universal cure for Hemophilia A or B patients with or without inhibitors to their missing clotting...
Recent Comments